Double Blind, Double Dummy, Cross-over Study to Compare the Bronchodilator Effect of CHF1535 pMDI (Fixed Combination of Beclometasone 50 microg + Formoterol 6 microg) Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children
Phase of Trial: Phase II
Latest Information Update: 03 Apr 2017
At a glance
- Drugs Beclometasone/formoterol (Primary) ; Beclometasone; Formoterol
- Indications Asthma
- Focus Pharmacodynamics
- Acronyms PAED3
- Sponsors Chiesi
- 21 Apr 2015 New source identified and integrated (European Clinical Trials Database record: EudraCT2011-002060-24)
- 23 Nov 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Jan 2013 Planned End Date changed from 1 Dec 2012 to 1 May 2013 as reported by ClinicalTrials.gov.